Validations: Post-Launch Stabilization & CPV Handover
Biologics & ATMPs: CPV Considerations Understanding Continued Process Verification in Biologics and ATMPs Continued Process Verification (CPV) is a crucial component in the lifecycle management of Biologics and Advanced Therapy Medicinal Products (ATMPs). It signifies an evolution from traditional quality assurance approaches to a more continuous and proactive methodology. Under the FDA, EU GMP Annex 15, and other regulatory frameworks,…
Combination Products Post-Launch: CPV Tailoring Combination Products Post-Launch: CPV Tailoring Introduction to Continued Process Verification (CPV) Combination products represent an essential segment of the pharmaceutical industry, merging drugs, devices, and biological products to improve therapeutic outcomes. As these products transition from the development phase to post-launch activities, a comprehensive approach to continued process verification (CPV) is critical. CPV not only…
Parametric Release Environments: CPV Hooks Parametric Release Environments: CPV Hooks Introduction to Parametric Release and Continued Process Verification (CPV) In the pharmaceutical industry, ensuring product quality throughout the lifecycle is paramount. As regulatory expectations evolve, continued process verification (CPV) is becoming an increasingly important element of the overall validation framework. CPV not only helps in maintaining compliance with standards such…
Integrating Complaint and Field Failure Signals into Continued Process Verification: Feedback Loops Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is essential for ensuring the ongoing quality and efficacy of pharmaceutical products post-launch. It is part of a regulatory shift that emphasizes quality over conformity, reflecting the principles outlined in regulations such as the FDA process validation guidelines,…
Complaint/Field Failure Signals into CPV: Feedback Loops Complaint/Field Failure Signals into CPV: Feedback Loops Introduction to Continued Process Verification In the pharmaceutical industry, the transition from product launch to continued process verification (CPV) is critical for ensuring product quality and compliance with regulatory standards. CPV serves as a cornerstone of FDA process validation, incorporating a systematic approach to monitoring performance…
Parametric Release Environments: CPV Hooks Parametric Release Environments: CPV Hooks In the pharmaceutical industry, ensuring product quality through validated processes is paramount. The FDA, EMA, and other regulatory bodies emphasize the importance of continued process verification (CPV) within the framework of the overall validation lifecycle. This article serves as a comprehensive guide, detailing the requirements, methodologies, and templates essential for…
Combination Products Post-Launch: CPV Tailoring Understanding Continued Process Verification (CPV) In the realm of pharmaceutical development and manufacturing, continued process verification (CPV) serves as a vigilant overseer post-launch. Following the completion of lifecycle-appropriate validation phases, including FDA process validation, a robust CPV strategy emerges paramount to assure product consistency and quality. This necessity stems from the ever-evolving nature of manufacturing…
Biologics & ATMPs: CPV Considerations Biologics & ATMPs: CPV Considerations Introduction to Continued Process Verification (CPV) In the context of biologics and advanced therapy medicinal products (ATMPs), Continued Process Verification (CPV) represents a critical approach for ensuring quality and consistency post-commercialization. CPV is an integral part of the regulatory expectations set forth by agencies such as the FDA and the…
Top 20 CPV Findings—and How to Avoid Them Top 20 CPV Findings—and How to Avoid Them Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is a crucial aspect of modern pharmaceutical manufacturing that ensures processes continue to operate within specifications following process validation. The regulatory landscape, particularly as guided by the FDA, emphasizes the need for robust CPV…
Top 20 CPV Findings—and How to Avoid Them Top 20 CPV Findings—and How to Avoid Them Continued Process Verification (CPV) is a critical component in the lifecycle management of pharmaceutical products, ensuring their quality and safety post-launch. Regulatory bodies like the FDA, the EMA, and the MHRA emphasize CPV as part of the broader FDA process validation framework. This article…